An Exploratory Behavioral Intervention Trial to Improve Rates of Screening for AIDS Clinical Trials Among Racial/Ethnic Minority and Female Persons Living with HIV/AIDS
- 170 Downloads
Individuals from racial/ethnic minority backgrounds and women have not been proportionately represented in AIDS clinical trials (ACTs). There have been few intervention efforts to eliminate this health disparity. This paper reports on a brief behavioral intervention to increase rates of screening for ACTs in these groups. The study was exploratory and used a single-group pre/posttest design. A total of 580 persons living with HIV/AIDS (PLHA) were recruited (39% female; 56% African-American, 32% Latino/Hispanic). The intervention was efficacious: 25% attended screening. We identified the primary junctures where PLHA are lost in the screening process. Both group intervention sessions and an individual contact were associated with screening. Findings provide preliminary support for the intervention’s efficacy and the utility of combining group and individual intervention formats. Interventions of greater duration and intensity, and which address multiple levels of influence (e.g., social, structural), may be needed to increase screening rates further.
KeywordsHIV/AIDS clinical trials Behavioral intervention Screening Gender disparities Racial/ethnic disparities Motivational interviewing
- Allison, P. D. (1999). Logistic regression using the SAS system: Theory and application. Cary, NC: SAS Institute.Google Scholar
- Anderson, D. (2004). A guide to patient recruitment and retention. Boston, MA: Thomson CenterWatch.Google Scholar
- Bandura, A. (1986). Social foundations of thought and action. Englewood Cliffs, NJ: Prentice Hall.Google Scholar
- Centers for Disease Control and Prevention. (2005). Viral hepatitis, STD and TB prevention HIV/AIDS among African-American. Retrieved June 15, 2007, from http://www.cdc.gov/hiv/topics/aa/resources/factsheets/aa.htm.
- Centers for Disease Control and Prevention. (2006a). HIV/AIDS among Hispanics. Retrieved April 15, 2008, from http://www.cdc.gov/hiv/hispanics/resources/factsheets/hispanic.htm.
- Centers for Disease Control and Prevention. (2006b). Racial/ethnic disparities in diagnoses of HIV/AIDS—33 states, 2001–2004. MMWR, 55(5), 121–125.Google Scholar
- Ding, E. L., Powe, N. R., Manson, J. E., Sherber, N. S., & Braunstein, J. B. (2007). Sex differences in perceived risks, distrust, and willingness to participate in clinical trials. A randomized study of cardiovascular prevention trials. Archives of Internal Medicine, 167(9), 905–912. doi:10.1001/archinte.167.9.905.CrossRefPubMedGoogle Scholar
- Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R. H., Watters, J., Andersen, M., et al. (1994). Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383–392.Google Scholar
- Gandhi, M., Ameli, N., Bacchetti, P., Sharp, G. B., French, A. L., Young, M., et al. (2005). Eligibility criteria for HIV clinical trials and generalizability of results: The gap between published reports and study protocols. AIDS (London, England), 19(16), 1885–1896. doi:10.1097/01.aids.0000189866.67182.f7.Google Scholar
- Gifford, A. L., Cunningham, W. E., Heslin, K. C., Andersen, R. M., Nakazono, T., Lieu, D. K., et al. (2002). Participation in research and access to experimental treatments by HIV-infected patients. The New England Journal of Medicine, 346(18), 1373–1382. doi:10.1056/NEJMsa011565.CrossRefPubMedGoogle Scholar
- Gwadz, M. V., Leonard, N. R., Nakagawa, A., Cylar, K., Finkelstein, M., Herzog, N., et al. (2006). Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgrounds. AIDS Care, 18(7), 786–794. doi:10.1080/09540120500428952.CrossRefPubMedGoogle Scholar
- Hankins, C., Lapointe, N., & Walmsley., S. (1998). Participation in clinical trials among women living with HIV in Canada. Canadian Medical Association, 159(11), 1359–1365.Google Scholar
- Harrell, F. E., Margolis, P. A., Gove, S., Mason, K. E., Mulholland, E. K., Lehmann, D., et al. (1998). Development of a clinical prediction model for an ordinal outcome: The World Health Organization multicentre study of clinical signs and etiological agents of pneumonia, sepsis and meningitis in young infants. WHO/ARI Young Infant Multicentre Study Group. Statistics in Medicine, 17(8), 909–944. doi:10.1002/(SICI)1097-0258(19980430)17:8≤909::AID-SIM753≥3.0.CO;2-O.CrossRefPubMedGoogle Scholar
- Harris Interactive. (2000). Cancer clinical trials: Opportunities for increasing enrollment (study no. 11799). Harris Interactive, Inc.: New York.Google Scholar
- Killien, M., Bigby, J. A., Champion, V., Fernandez-Repollet, E., Jackson, R. D., Kagawa-Singer M., et al. (2000). Involving minority and underrepresented women in clinical trials: The National Centers of Excellence in Women's Health. Journal of Women's Health & Gender-Based Medicine, 9(10), 1061–1070.CrossRefGoogle Scholar
- King, W. D., Defreitas, D., Smith, K., Andersen, J., Perry, L. P., Adeyemi, T., et al. (2007). Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: A descriptive study. AIDS Patient Care and STDs, 21(8), 551–563. doi:10.1089/apc.2006.0173.CrossRefPubMedGoogle Scholar
- Marshak, A., Costantini, G., Middleton, S., Barnett, S., Garmon, D., Gwadz, M., Leonard, N., Nakagawa, A., Mildvan, D., & Project ACT Collaborative Research Team. (2007). Screening for AIDS clinical trials in the project ACT cohort of racial/ethnic minorities and women in New York City: Substantial interest but low eligibility. Abstract published in CD-ROM. IAS conference on hiv pathogenesis, treatment and prevention, Sydney, Australia.Google Scholar
- Miller, W., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York: Guilford.Google Scholar
- National Institute of Allergy and Infectious Diseases. (2005). HIV infection in minority populations. Retrieved April 5, 2008, from http://www.niaid.nih.gov/factsheets/Minor.htm.
- National Institute on Drug Abuse. (1991). Risk behavior assessment. Bethesda, MD: Community Research Branch, National Institute on Drug Abuse.Google Scholar
- Nova Research Company. (2001). Questionnaire Development System (version 2) [computer software]. Bethesda, MD: Nova Research Company.Google Scholar
- Parada, J. (2000). The changing face of AIDS. Minority Health Today, 1(5), 9–17.Google Scholar
- RAND Corporation. (1995). HIV cost and services utilization study (HCSUS) baseline questionnaire. Santa Monica, CA: RAND.Google Scholar
- Shapiro, M., Morton, S., McCaffrey, D., Senterfitt, J., Fleishman, J., Perlman, J., et al. (1999). Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. Journal of the American Medical Association, 281(24), 2305–2315. doi:10.1001/jama.281.24.2305.CrossRefPubMedGoogle Scholar